User profiles for M. K. Koenig

Mary Kay Koenig

Professor of Child & Adolescent Neurology, University of Texas McGovern Medical School
Verified email at uth.tmc.edu
Cited by 7298

[HTML][HTML] Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

…, U Bartels, M Berhouma, DN Franz, MK Koenig… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is highly variable in clinical presentation and
findings. Disease manifestations continue to develop over the lifetime of an affected individual. …

[HTML][HTML] Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

…, U Bartels, M Berhouma, DN Franz, MK Koenig… - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is a genetic disorder affecting every organ system,
but disease manifestations vary significantly among affected individuals. The diverse and …

[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations

…, SR Johnson, B King, JC Kingswood, MK Koenig… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

[HTML][HTML] Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

S Parikh, A Goldstein, MK Koenig, F Scaglia… - Genetics in …, 2015 - nature.com
Purpose: The purpose of this statement is to review the literature regarding mitochondrial
disease and to provide recommendations for optimal diagnosis and treatment. This statement …

[HTML][HTML] Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

S Parikh, A Goldstein, A Karaa, MK Koenig, I Anselm… - Genetics in …, 2017 - Elsevier
The purpose of this statement is to provide consensus-based recommendations for optimal
management and care for patients with primary mitochondrial disease. This statement is …

[HTML][HTML] Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management

DE Meyers, HI Basha, MK Koenig - Texas Heart Institute Journal, 2013 - ncbi.nlm.nih.gov
Mitochondrial disease is a heterogeneous group of multisystemic diseases that develop
consequent to mutations in nuclear or mitochondrial DNA. The prevalence of inherited …

[HTML][HTML] Reanalysis of clinical exome sequencing data

…, K Gripp, S Kleppe, MK Koenig… - … England Journal of …, 2019 - Mass Medical Soc
Reanalysis of Clinical Exome Data and Diagnostic Yield As knowledge about genetic
causes of disease improves, periodic reanalysis of clinical exome sequence could yield new …

[HTML][HTML] Tuberous sclerosis complex

H Northrup, MK Koenig, DA Pearson, KS Au - 2021 - europepmc.org
Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic macules,
confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic plaques, …

Presentation and diagnosis of mitochondrial disorders in children

MK Koenig - Pediatric neurology, 2008 - Elsevier
The first disorder of mitochondrial function was described by Luft in 1959. Over the ensuing
decades, multiple cases of mitochondrial dysfunction were reported, and the term “…

[HTML][HTML] Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex …

J Roth, ES Roach, U Bartels, S Jóźwiak, MK Koenig… - Pediatric Neurology, 2013 - Elsevier
Background Tuberous sclerosis complex is an autosomal dominant disorder predisposing to
the development of benign lesions in different body organs, mainly in the brain, kidney, liver…